Transfer of Diabetes from Prediabetic NOD Mice to NOD-SCID/SCID Mice: Association with Pancreatic Insulin Content

Abstract

Splenocytes from prediabetic female NOD mice can transfer diabetes to NOD-SCID mice. Whereas the kinetics of disease transfer was shown to be a function of the age of donor splenocytes, information is scarce as to how the stage of autoimmune disease, as evaluated by pancreatic insulin content, is related to the diabetogenic potency of splenic T-cells. We therefore determined individual diabetes transfer times after an i. v. injection of splenocytes from prediabetic NOD mice of different ages into female NOD-SCID mice in relation to the diabetes incidence in NOD donor mice and their pancreatic insulin contents. Three groups (n = 8) of NOD mice aged 5, 11, and 17 weeks (wk) underwent splenectomy and hemipancreatectomy. After that, 10×10⁶ splenocytes either pooled from all donor NOD mice of the different age groups or individually from single donor mice were transferred to groups of four 6-week-old NOD-SCID mice, respectively, in two sets of experiments. Insulin was extracted from the resected hemipancreas, and the insulin content was determined by a RIA. Diabetes in the NOD-SCID cohort occurred after a mean time of 126 days after transfer of pooled splenocytes from 5-week-old NODs, after 68 days (transfer from 11-week-old NODs), and after a mean time of 43 days (transfer from 17-week-old NODs, 5 vs. 11 wk: p < 0.02, 11 vs. 17 wk: p < 0.001). Individual time to diabetes positively correlated with diabetes transfer times in NOD-SCID recipients (p < 0.0001) in the 17-week-old NOD mice, confirming previous diabetes transfer studies in hemi-pancreatectomized NOD mice. Furthermore, individual insulin concentrations in 17-week-old NOD mice also positively correlated to diabetes transfer times in recipient mice (p < 0.0001). No such correlations for these parameters were seen for the 5 and 11-week-old NOD mice (time to diabetes: 11 wk, p = 0.14, 5 wk, p = 0.75; insulin content: 11 wk, p = 0.81, 5 wk, p = 0.14). These data suggest that destructive T-cell activity increases during the course of islet autoimmunity. The immune response seems to be programmed for β-cell destruction just before diabetes onset. This is the only time that pancreatic insulin content predicts the impending onset of diabetes.

NOD mouse - NOD-scid mouse - Pancreatic insulin content - Diabetes transfer - Prediabetes - Islet autoimmunity

References

• 1 Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Fujino-Kurihara K, Tochino Y. Breeding of a non-obese, diabetic strain of mice.  Jikken Dobutsu. 1980;  29 1-13
• 2 Tisch R, Yang X D, Singer S M, Liblau R S, Fugger L, McDevitt H O. Immune responses to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.  Nature. 1993;  366 72-75
• 3 Ziegler A G, Vardi P, Ricker A T, Hattori M, Soeldner J S, Eisenbarth G S. Radioassay determination of insulin autoantibodies in NOD mice: correlation with increased risk of progression to overt diabetes.  Diabetes. 1989;  38 3358-3363
• 4 Larger E, Becourt C, Bach J F, Boitard C. Pancreatic islet β cells drive T cell-immune responses in the Nonobese Diabetic mouse model. J Exp.  Med. 1995;  181 1635-1642
• 5 Christianson S W, Shultz L D, Leiter E H. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4⁺ and CD8⁺ T-cells from diabetic versus prediabetic NOD.NON-Thy-1^a donors.  Diabetes. 1993;  42 44-55
• 6 Shimada A, Charlton B, Taylor-Edwards C, Fathman C G. β-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice.  Diabetes. 1996;  45 1063-1067
• 7 Signore A, Proccacini E, Toscano A M, Ferretti E, Williams A J, Beales P E, Cugini P, Pozzilli P. Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse.  Histochemistry. 1994;  101 263-269
• 8 Wicker L S, Miller B J, Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from Nonobese diabetic (NOD) mice.  Diabetes. 1986;  35 855-860
• 9 Morgan C R, Lazarow A. Immunoassay of pancreatic and plasma insulin following alloxan injections of rats.  Diabetes. 1965;  14 669-671
• 10 Itoh A, Maki T. Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis.  PNAS. 1996;  93 11 053-11 056
• 11 Walter U, Toepfer T, Dittmar K E, Kretschmer K, Lauber J, Weiss S, Servos G, Lechner O, Scherbaum W A, Bornstein S R, von Boehmer H, Buer J. Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes.  Diabetologia. 2003;  46 1106-1114
• 12 Prochazka M, Gaskins H, Schultz L, Leiter E. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency.  Proc Natl Acad Sci. 1992;  89 3290-3294
• 13 Rohane P, Shimada A, Kim D T, Edwards C T, Charlton B, Shultz L D, Fathman C G. Islet infiltrating lymphocytes from prediabetic NOD Mice rapidly transfer Diabetes to NOD-Scid/scid Mice.  Diabetes. 1995;  44 550-554
• 14 Peterson J, Haskins K. Transfer of Diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.  Diabetes. 1996;  45 328-336
• 15 Rahier J, Wallon J, Henquin J C. Cell populations in the Endocrine Pancreas of Human and Infants.  Diabetologia. 1981;  20 540-546
• 16 Slack J MW. Developmental biology of the pancreas.  Development. 1995;  121 1569-1580